Umoja Biopharma’s Seattle facility, located in the Eastlake neighborhood, serves as the company’s corporate headquarters and primary research and development center.
This site is integral to Umoja’s mission of developing in vivo CAR T cell therapies and housing key leadership, scientific, and operational teams. The facility supports the company’s innovative approaches to cancer treatment, leveraging its proprietary VivoVec platform to generate CAR T cells directly within patients’ bodies.
WT provided cost management services for this project, including budgeting, cost estimating, and financial oversight, ensuring the facility met its financial objectives while supporting Umoja’s scientific goals.